Early Diagnosis of Respiratory Disease in Light of COVID-19 Infection and Use of Oxygen Concentrators and CPAP Devices for the Treatment of Respiratory Failure

Authors

  • M. W. Alhamd Directorate of Research and Development/ Iraqi Atomic Energy Commission – Iraq
  • Ali Jassem Abdolhusain Directorate of Research and Development/ Iraqi Atomic Energy Commission – Iraq
  • Yahia Jaafar Lola Directorate of Research and Development/ Iraqi Atomic Energy Commission – Iraq
  • Mazen Abbas Al-Gharrawy Directorate of Research and Development/ Iraqi Atomic Energy Commission – Iraq

DOI:

https://doi.org/10.53523/ijoirVol10I1ID298

Keywords:

Pulse oximetry, Apnea, Coronavirus infection COVID-19, CPAP therapy, Chronic obstructive pulmonary disease

Abstract

The need for early diagnosis of respiratory diseases, especially in the context of the COVID-19 coronavirus infection pandemic, by means of pulse oximetry screening and monitoring has been substantiated. The expediency of using portable pulse oximeters by therapists and general practitioners is shown. The main respiratory diseases accompanied by respiratory failure, which can be promptly detected by pulse oximetry, are chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome. Early detection of these diseases is an urgent task due to the low severity of symptoms of these diseases in the early stages and, as a consequence, the prevalence of late diagnosis. Pulse oximetry to detect coronavirus infection COVID-19 deserves special attention, since this infection is also accompanied by respiratory failure. The use of oxygen concentrators and CPAP devices for the treatment of respiratory failure has been argued. The effectiveness of the appointment of long-term oxygen therapy using oxygen concentrators in patients with chronic obstructive pulmonary disease, CPAP therapy using automatic CPAP devices in patients with obstructive sleep apnea-hypopnea syndrome with mandatory pulse oximetry monitoring has been confirmed. A retrospective analysis of 120 cases of treatment of moderate and severe COVID-19 infection complicated by the development of pneumonia was carried out. The efficiency of using oxygen concentrators to supply patients with oxygen at a flow rate of up to 5 l / min has been proven. It was found that no more than 10% of patients needed an oxygen flow at a rate of more than 5 l/min. At the same time, the possibility of using CPAP devices for non-invasive ventilation of the lungs using full-face masks has been shown. The expediency of using oxygen concentrators and CPAP devices for the rehabilitation of patients who have undergone COVID-19 was noted.

Downloads

Published

2023-06-14

How to Cite

Alhamd, M. W., Abdolhusain, A. J., Lola, Y. J., & Al-Gharrawy, M. A. (2023). Early Diagnosis of Respiratory Disease in Light of COVID-19 Infection and Use of Oxygen Concentrators and CPAP Devices for the Treatment of Respiratory Failure. Iraqi Journal of Industrial Research, 10(1), 34–40. https://doi.org/10.53523/ijoirVol10I1ID298

Issue

Section

Engineering Section